Targeting the <scp>PTP1B‐Bcr‐Abl1</scp> interaction for the degradation of <scp>T315I</scp> mutant <scp>Bcr‐Abl1</scp> in chronic myeloid leukemia
Ahmed Elgehama(Stony Brook Medicine), Qiang Xu(China Pharmaceutical University), Jian Gao(Hebei Medical University), Biao Yu(Chinese Academy of Sciences), Yan Shen(Zhejiang Chinese Medical University), Zhixiu Chen(Nanjing University), Liwei Wang(Renji Hospital), Yixuan Wang(Nanjing University), Ying Yu(Peking University), Lijun Sun(Howard Hughes Medical Institute), Lin Zhou(Xiamen University)
Cited by 5
Related Papers
A Genome-Wide Search for Signals of High-Altitude Adaptation in Tibetans
|Molecular Biology and Evolution|2010|342
Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs
|Nature Biotechnology|2019|286
KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner
|Oncogene|2019|265